cloricromen has been researched along with Alloxan Diabetes in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bucolo, C; Cuzzocrea, S; Drago, F; Mazzon, E; Ward, KW | 1 |
| Allegri, G; Bertazzo, A; Caparrotta, L; Comai, S; Costa, CV; Ragazzi, E | 1 |
2 other study(ies) available for cloricromen and Alloxan Diabetes
| Article | Year |
|---|---|
Protective effects of a coumarin derivative in diabetic rats.
Topics: Animals; Antigens, CD; Blood-Retinal Barrier; Blotting, Western; Cadherins; Chromonar; Claudin-5; Diabetes Mellitus, Experimental; Diabetic Retinopathy; Enzyme-Linked Immunosorbent Assay; Immunohistochemistry; Injections, Intraperitoneal; Intercellular Adhesion Molecule-1; Male; Membrane Proteins; Nitric Oxide Synthase Type III; Occludin; Phosphoproteins; Platelet Aggregation Inhibitors; Rats; Rats, Sprague-Dawley; Tumor Necrosis Factor-alpha; Tyrosine; Vascular Endothelial Growth Factor A; Zonula Occludens-1 Protein | 2009 |
Cloricromene effect on the enzyme activities of the tryptophan-nicotinic acid pathway in diabetic/hyperlipidemic rabbits.
Topics: Animals; Cholesterol, Dietary; Chromonar; Diabetes Mellitus, Experimental; Free Radical Scavengers; Hyperlipidemias; Intestine, Small; Liver; Male; Niacin; Oxidation-Reduction; Oxygenases; Platelet Aggregation Inhibitors; Rabbits; Tryptophan | 2006 |